How I treat idiopathic patients with inflammatory myopathies in the clinical practice

被引：24
作者：
Cavagna, Lorenzo [1 ]
Monti, Sara [1 ]
Caporali, Roberto [1 ]
Gatto, Mariele [2 ]
Iaccarino, Luca [2 ]
Doria, Andrea [2 ]
机构：
[1] Univ Pavia, IRCCS Policlin S Matteo Fdn, Dept Rheumatol, I-27100 Pavia, Italy
[2] Univ Padua, Dept Med, Rheumatol Unit, Padua, Italy
来源：
AUTOIMMUNITY REVIEWS | 2017年 / 16卷 / 10期
关键词：
Idiopathic inflammatory myopathies; Antisynthetase syndrome; Therapy; Glucocorticoids; Immunosuppressants; INTERSTITIAL LUNG-DISEASE; RECALCITRANT JUVENILE DERMATOMYOSITIS; INTRAVENOUS IMMUNOGLOBULIN THERAPY; LOW-DOSE METHOTREXATE; ANTISYNTHETASE SYNDROME; MYCOPHENOLATE-MOFETIL; PULMONARY-HYPERTENSION; CALCINOSIS CUTIS; REFRACTORY ADULT; CYCLOSPORINE-A;
D O I：
10.1016/j.autrev.2017.07.016
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Management of patients with idiopathic inflammatory myopathies (Ms) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码：999 / 1007
页数：9
相关论文
共 157 条
  • [51] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Sanchez, Miguel Angel Gomez
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 903 - 975
  • [52] Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis
    Galimberti, Fabrizio
    Li, Yumeng
    Fernandez, Anthony P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : 174 - +
  • [53] Topical tacrolimus in cutaneous lesions of dermatomyositis: Lack of effect in side-by-side comparison in five patients
    Garcia-Doval, I
    Cruces, M
    [J]. DERMATOLOGY, 2004, 209 (03) : 247 - 248
  • [54] Severe adult dermatomyositis with unusual calcinosis
    Garel, Bethsabee
    Barete, Stephane
    Rigolet, Aude
    Le Pelletier, Francois
    Benveniste, Olivier
    Hervier, Baptiste
    [J]. RHEUMATOLOGY, 2015, 54 (11) : 2024 - 2024
  • [55] The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review
    Ge, Yongpeng
    Zhou, Hang
    Shi, Jingli
    Ye, Bin
    Peng, Qinglin
    Lu, Xin
    Wang, Guochun
    [J]. CLINICAL RHEUMATOLOGY, 2015, 34 (12) : 2097 - 2103
  • [56] Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review
    Ge, Yongpeng
    Peng, Qinglin
    Zhang, Sigong
    Zhou, Hang
    Lu, Xin
    Wang, Guochun
    [J]. CLINICAL RHEUMATOLOGY, 2015, 34 (01) : 99 - 105
  • [57] Gelber AC, 2000, J RHEUMATOL, V27, P1542
  • [58] Anti-Mi-2 antibodies
    Ghirardello, A
    Zampieri, S
    Iaccarino, L
    Tarricone, E
    Bendo, R
    Gambari, PF
    Doria, A
    [J]. AUTOIMMUNITY, 2005, 38 (01) : 79 - 83
  • [59] Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease
    Go, Dong Jin
    Park, Jin Kyun
    Kang, Eun Ha
    Kwon, Hyun Mi
    Lee, Yun Jong
    Song, Yeong Wook
    Lee, Eun Bong
    [J]. RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 125 - 131
  • [60] Göttfried I, 2000, EUR J DERMATOL, V10, P29
12345678910